LQDA logo

LIQUIDIA CORP

LQDANASDAQ
🏆 #1122 by market capEarnings Nov 2US Equity
$382.63▲ $1.15 (+0.30%)
Simulated price
🔔
Track LQDA
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 0.3%
7d▲ 457.9%
14d▲ 482.3%
30d▲ 466.0%
ytd▲ 1008.4%
1y▲ 1578.9%
🏦Market Cap
$6.59B
Small Cap
📈Revenue Growth (YoY)
+2233.7%
High Growth
📊Gross Margin
92.6%
High
💵FCF Margin
—
⚖️P/S Ratio
14.6x
Expensive
Otter Score
52
Weak

Trading Snapshot

Day Range
$376.63 – $386.47
52-Week Range
$21.15 – $93.61
Volume
$2.80B
Avg Volume
$2.52B
Shares Outstanding
88.9M
Next Earnings
Oct 22, 2026

Fundamentals Snapshot

Annual Revenue
$158M
Last Q Revenue
$172M
P/E Ratio
47.6
P/S Ratio
14.6x
EPS (TTM)
$1.39
Dividend Yield
—
Dilution (1yr)
+18.1%

Why Investors Own LQDA

  • ✓High-growth profile — revenue up +58.0% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 74% gross margin and 21% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

LQDA logo

LIQUIDIA CORP

LQDA
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$158M▲ +1031.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
91.6%▲ +58.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$51M▼ −57.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$40M▼ −59.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
100.1M▲ +18.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$7M▼ −$61M YoY
StockOtter · stockotter.space

About LIQUIDIA CORP

Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
52/100

Analyst Price Target

ⓘ
Average Target
$409.73
▲ +7.1% Upside
High Target$494.20
Low Target$340.34
Based on 25 analysts

Latest News & Updates

🚀
MarketWatch·2h ago

LIQUIDIA CORP tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Barron’s·5h ago

Analysts lift LQDA price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Bloomberg·1d ago

LIQUIDIA CORP announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.